Traws Pharma Inc./$TRAW
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Traws Pharma Inc.
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
Ticker
$TRAW
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
7
ISIN
US68232V8845
Website
TRAW Metrics
BasicAdvanced
$9.6M
-
-$11.22
1.47
-
Price and volume
Market cap
$9.6M
Beta
1.47
52-week high
$3.75
52-week low
$0.97
Average daily volume
2.3M
Financial strength
Current ratio
1.813
Quick ratio
1.691
Management effectiveness
Return on assets (TTM)
-83.59%
Return on equity (TTM)
-2,331.25%
Valuation
Price to revenue (TTM)
23.366
Price to book
1.6
Price to tangible book (TTM)
1.45
Price to free cash flow (TTM)
-0.172
Growth
Revenue change (TTM)
0.44%
Earnings per share change (TTM)
-48.05%
3-year revenue growth (CAGR)
0.15%
3-year earnings per share growth (CAGR)
-19.04%
TRAW News
AllArticlesVideos
Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
GlobeNewsWire·1 week ago
Traws Pharma Announces Management Updates
GlobeNewsWire·2 months ago
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Traws Pharma Inc. stock?
Traws Pharma Inc. (TRAW) has a market cap of $9.6M as of June 06, 2025.
What is the P/E ratio for Traws Pharma Inc. stock?
The price to earnings (P/E) ratio for Traws Pharma Inc. (TRAW) stock is 0 as of June 06, 2025.
Does Traws Pharma Inc. stock pay dividends?
No, Traws Pharma Inc. (TRAW) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next Traws Pharma Inc. dividend payment date?
Traws Pharma Inc. (TRAW) stock does not pay dividends to its shareholders.
What is the beta indicator for Traws Pharma Inc.?
Traws Pharma Inc. (TRAW) has a beta rating of 1.47. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.